| RS1692739694 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS1692740329 |
CNGA3
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1692797868 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1692799480 |
CNGA3
|
Health Risk |
Pathogenic |
Cone dystrophy, Cone dystrophy |
| RS1692819940 |
CUL3
|
Health Risk |
Pathogenic |
— |
| RS1692821181 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS1692821396 |
CUL3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1692824104 |
CUL3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1692862061 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1692866593 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1692870117 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1692870573 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1692873873 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |
| RS1692876152 |
STAT1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS1692878257 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1692895957 |
LOC102724058;SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1692898861 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia, Achromatopsia |
| RS1692904914 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1692905818 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1692906608 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1692907593 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS1692911763 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1692914478 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1692915919 |
CNGA3
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1692916541 |
CNGA3
|
Health Risk |
Likely pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1692918950 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS1692920727 |
CUL3
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2E, Pseudohypoaldosteronism type 2E |
| RS1692921014 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1692928194 |
CNGA3
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1692930941 |
CNGA3
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1692932180 |
CNGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1692935801 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS16929375 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS1692945934 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1693019491 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693032325 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1693042024 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Malignant tumor of breast |
| RS1693044156 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693048371 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group L |
| RS1693074467 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693089850 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693089932 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693164213 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1693173657 |
ALS2
|
Health Risk |
Pathogenic |
— |
| RS1693176153 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1693198121 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1693198997 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1693228350 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1693267402 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1693309648 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1693333622 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1693383784 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS1693396597 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1693432220 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS1693433379 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS1693439048 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS1693439187 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS1693462968 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1693467305 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis, Progressive familial intrahepatic cholestasis |
| RS1693477912 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1693501054 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1693504040 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693509336 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1693517014 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1693519718 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1693554666 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693556617 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693559368 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693577284 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693604030 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS1693624356 |
SPEG
|
Health Risk |
Likely pathogenic |
Myopathy, centronuclear |
| RS1693633153 |
FANCD2
|
Health Risk |
Pathogenic |
— |
| RS1693635796 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1693682030 |
SCN9A
|
Health Risk |
Pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1693689203 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693691531 |
SCN1A-AS1;SCN9A
|
Health Risk |
Pathogenic |
— |
| RS1693718752 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1693726956 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, ALS2-related disorder |
| RS1693746784 |
SPEG
|
Health Risk |
Likely pathogenic |
— |
| RS1693751220 |
STAT1
|
Health Risk |
Pathogenic |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS1693752377 |
STAT1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Immunodeficiency 31B |
| RS1693752801 |
STAT1
|
Health Risk |
Likely pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Immunodeficiency 31B |
| RS1693769972 |
DIS3L2
|
Health Risk |
Pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1693780539 |
ALS2
|
Health Risk |
Pathogenic |
Juvenile primary lateral sclerosis, Juvenile primary lateral sclerosis |
| RS1693892555 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693893975 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693919240 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1693994454 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1693996119 |
STAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS1694058443 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1694058662 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1694059874 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1694062061 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1694065388 |
SLC4A10
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities, Neurodevelopmental disorder with hypotonia and characteristic brain abnormalities |
| RS16941 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1694125419 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1694160600 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS1694168766 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS16942 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1694228284 |
SATB1
|
Health Risk |
Pathogenic |
Developmental delay with dysmorphic facies and dental anomalies, Developmental delay with dysmorphic facies and dental anomalies |